Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil dose-ranging for laryngeal mask airway insertion with thiopental
ACTRN12625000175471Phase 4Completed
- Sponsor
- Firat University
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remifentanil and thiopental in Not applicable (4 arms), sponsored by Firat University. Primary endpoints: LMA insertion conditions and success and Hemodynamic response. Started Oct 2013; status: completed.
02
Drugs
remifentanilthiopental
03
Conditions
Not applicable
Beyond the preview
Go deeper on ACTRN12625000175471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000175471.